Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Biomolecular Concepts
|
December 2, 2014
Epigenetic drugs in Alzheimer's disease
Mar Cuadrado-Tejedor, Julen Oyarzabal, María Pascual Lucas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
María Pascual-Lucas, Ana María Lacosta, María Montañés, et al.
Journal of Alzheimer'S Disease : JAD
|
June 4, 2016
Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease
José Antonio Allué, Leticia Sarasa, María Izco, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
June 5, 2023
Clinical utility of an antibody-free LC-MS method to detect brain amyloid deposition in cognitively unimpaired individuals from the screening visit of the A4 Study
José Antonio Allué, María Pascual-Lucas, Leticia Sarasa, et al.
Frontiers in Aging Neuroscience
|
March 31, 2023
Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity
Min Young Chun, Hyemin Jang, Hee Jin Kim, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
José Antonio Allué, Leticia Sarasa, María Pascual-Lucas, et al.
Frontiers in Aging Neuroscience
|
October 27, 2025
Clinical validation of a plasma-based antibody-free LC-MS method for identifying CSF amyloid positivity in mild cognitive impairment
José Antonio Allué, Leticia Sarasa, Noelia Fandos, et al.
Neuropharmacology
|
July 11, 2012
Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD
Carolina García-Barroso, Ana Ricobaraza, María Pascual-Lucas, et al.
Alzheimer'S Research & Therapy
|
January 5, 2023
Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline
María Pascual-Lucas, José Antonio Allué, Leticia Sarasa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 8, 2025
Safety, tolerability, immunogenicity, and efficacy of ABvac40 active immunotherapy against Aβ40 in patients with mild cognitive impairment or very mild Alzheimer's disease: A randomized, double-blind, placebo-controlled phase 2 study
María Pascual-Lucas, Ana María Lacosta, María Montañés, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Biomolecular Concepts
|
December 2, 2014
Epigenetic drugs in Alzheimer's disease
Mar Cuadrado-Tejedor, Julen Oyarzabal, María Pascual Lucas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
María Pascual-Lucas, Ana María Lacosta, María Montañés, et al.
Journal of Alzheimer'S Disease : JAD
|
June 4, 2016
Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease
José Antonio Allué, Leticia Sarasa, María Izco, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
June 5, 2023
Clinical utility of an antibody-free LC-MS method to detect brain amyloid deposition in cognitively unimpaired individuals from the screening visit of the A4 Study
José Antonio Allué, María Pascual-Lucas, Leticia Sarasa, et al.
Frontiers in Aging Neuroscience
|
March 31, 2023
Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity
Min Young Chun, Hyemin Jang, Hee Jin Kim, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
José Antonio Allué, Leticia Sarasa, María Pascual-Lucas, et al.
Frontiers in Aging Neuroscience
|
October 27, 2025
Clinical validation of a plasma-based antibody-free LC-MS method for identifying CSF amyloid positivity in mild cognitive impairment
José Antonio Allué, Leticia Sarasa, Noelia Fandos, et al.
Neuropharmacology
|
July 11, 2012
Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD
Carolina García-Barroso, Ana Ricobaraza, María Pascual-Lucas, et al.
Alzheimer'S Research & Therapy
|
January 5, 2023
Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline
María Pascual-Lucas, José Antonio Allué, Leticia Sarasa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 8, 2025
Safety, tolerability, immunogenicity, and efficacy of ABvac40 active immunotherapy against Aβ40 in patients with mild cognitive impairment or very mild Alzheimer's disease: A randomized, double-blind, placebo-controlled phase 2 study
María Pascual-Lucas, Ana María Lacosta, María Montañés, et al.
Page
of 2